LM-AMD-02

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameLM-AMD-02
Drug Alias NameLM-AMD-02
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLeadartis SL
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLeadartis SL
Active IndicationsN/A
Inactive IndicationsMacular Degeneration

Other Information

ATC CodeN/A
Related LinksN/A